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Introduction
The probability that a patient will achieve an ongoing pregnancy should be evaluated as accurately as possible before a patient enters a programme for in-vitro fertilization (IVF) and during the course of her treatment with IVF. In addition to the age of the woman and the aetiology of infertility (the standard indicators for success), better rules would be welcome for physicians when counselling a patient. Potential predictors of IVF success are; patient characteristics at entry to the programme, characteristics of the treatment itself and during treatment, and intermediate results.
Most studies on factors that may predict pregnancy after treatment with IVF have investigated only a few indicators, for instance age and the type of infertility (Piette et a l , 1990; Hull et a l , 1992; Check et a l, 1993) , baseline follicle stimulating hormone (FSH), luteinizing hormone (LH) and oestradiof concentrations (Padilla et a l , 1990) , ovulation stimulation treatment and ovarian response (Dor et a l , 1992) , endometrium thickness and uterine artery flow (Spernol et a l , 1993) , sperm characteristics (Enginsu et a l 1992) and age, oestradiol concentration, number and quality of oocytes and embryos (Fluker et a l , 1993) . However, various simultaneous factors may influence the probability of achieving an ongoing pregnancy after IVF It would therefore be desirable to create a model to predict the probability of achieving an ongoing pregnancy which includes all the relevant factors. Until now, only a few attempts have been made to do this for IVF (Hughes et a l t 1989; Haan et a l , 1991) and other assisted reproductive techniques (Guzick et a l , 1989; Nelson et a l , 1993) . In the study by Hughes et a l (1989) , age and failed fertilization due to poor sperm quality had a predictive value for success in subsequent IVF cycles. Haan et a l (1991) found that the probability of achieving an ongoing pregnancy after IVF treatment was increased by the presence of idiopathic infertility and decreased by the presence of a male factor, one ovary, the woman's age ^ 36 years, primary infertility of at least 5 years duration and by a higher number of previous IVF treatments. Multivariate prognostic models should not be confused with explanatory models such as recently published by Roseboom et a l (1995) . They discussed a multivariate model to explain the variation in the probability of pregnancy after embryo transfer. The variation was explained by the woman's age, average embryo morphology score, number of transferred embryos and an interaction term between tubal pathology and the woman's age. However, exclusion of the main effect of tubal pathology in the model makes a meaningful interpretation of the multivariate model difficult (Breslow and Day, 1980) and may cause bias (Kleinbaum et a l , 1982) . Moreover, their statement in the results section '...with a 1 year increase of'age, the probability of pregnancy for non-tubal patients decreased by 21%...' is obviously mistaken as a result of a wrong interpreta tion of the odds ratio in their study. Critical remarks can also be made about the methods used in the other four studies mentioned above (Guzick et a l , 1989; Hughes et a l , 1989; Haan et a l , 1991; Nelson et a l , 1993) . All the cycles were combined, irrespective of the number of previous IVF treatments and the number of treatments per patient. Some studies based the inclusion of factors on statistical significance of the relationship in univariate analyses, which can be influenced by other factors, instead of on the increase in 2298 the predictive power in multivariate models. Moreover, the predictions of these models were never tested in other popula tions. Thus, the validity of these prognostic models when used at other IVF centres can be questioned.
The purpose of this study is to create reliable models to predict the probability of achieving an ongoing pregnancy during the first or second treatment cycles with IVF. We used data from the University Hospital Nijmegen, The Netherlands, to develop the models, and data from another centre to test their predictive value.
Materials and methods
To develop the prognostic models, data were used from couples who were treated by IVF for the first time in the period March 1991 to January 1995 at the University Hospital, Nijmegen, The Netherlands. During this period IV F treatment hardly changed. To test these models, data were used from the Catharina Hospital, Eindhoven, The Netherlands. Guidelines on indications for IVF treatment in the Netherlands have been described by Jansen (1993) . In short, couples are only offered IVF treatment in case of bilateral tubopathology, in cases of unilateral tubopathology, male factor, endometriosis or cervical factor when other infertility treatments had not resolved the problem, and in case of idiopathic infertility after an infertility duration of at least 3 years. For both populations data were only included if the complete IVF treatment had been carried out at that particular IVF centre, no donor oocytes had been used and no intracytoplasmatic sperm injection (ICSI) had been performed. Patient characteristics prior to treatment are given in Table I .
Ongoing pregnancy was defined as a pregnancy which continued for longer than 12 weeks after embryo transfer. To predict the probability of achieving an ongoing pregnancy, three models were developed that employed different moments of prediction. To predict the probability of achieving an ongoing pregnancy during the first IVF treatment, model A was made at the start and model B at the time o f embryo transfer. For the prognosis of achieving an ongoing pregnancy during the second IVF treatment, model C was created at the end of the first IVF treatment. Table II presents the number of patients and pregnancies at each prediction moment.
Model A
This model was based on predictions made at the start of the first IV F cycle regarding the probability of achieving an ongoing pregnancy during the first IVF cycle. To develop this model, data were available from 757 couples whose first IVF cycle took place in Nijmegen. To induce ovulation, all the patients received a long protocol of gonadotrophin-releasing hormone (GnRH) agonist (usually Leuprolide; Abbott B.V., Amstelveen, The Netherlands or Suprefact; Hoechst Holland N.V., Amsterdam, The Netherlands) that was started on day 21 of the previous cycle and human menopausal gonadotrophin (HM G, Humegon; Organon Int. B.V., Oss, The Netherlands). Addi tionally, from August 199.1 to January 1994, all the patients received oral contraceptives during the cycle that preceded the IV F cycle. To improve synchronization of follicle growth, some women received oral contraceptives before or after this period. To test the model, data were available from 432 couples from Eindhoven who underwent their first IV F treatment between January 1990 and June 1995 (another five couples were excluded from this population because information about the occurrence of an ongoing pregnancy was lacking). In this test population, the type of ovulation induction used most often (92.2%) was a short protocol of GnRH agonist (usually Suprefact; I Prognosis of ongoing pregnancy after IVF $ Hoechst Holland N.V.) and HM G (Humegon, Organon Int. B.V.), in a few cases supplemented by progestins in the preceding cycle. Potential prognostic factors for the model that employed the onset of the first IVF cycle as the moment of prediction could only consist of information known at that moment, i.e. patient characteristics: age, period of infertility, reproductive history, basal FSH, indication(s) for IV F treatment, one or both ovaries present, sperm characteristics, anti-sperm antibodies in the woman or man, and information about the treatment protocol being used at that time: type of hormonal ovulation stimulation, maximum number of embryos that would be transferred, timing of human chorionic gonadotrophin (HCG) administration and type of culture medium. In Nijmegen, data on the duration of infertility were only available from patients who started IVF treatment between 1993-1994. Therefore the effect of the duration of infertility could only be estimated using the data from these 383 couples. Donor spermatozoa had not been used in Nijmegen, but it had been used in the test population in four and six patients during the first and second IVF cycles respectively. If donor spermatozoa had been used, the sperm characteristics were considered to be good and the indication for IVF 'male factor' was considered to be absent. We disregarded the results of cryopreserved embryo transfer.
Model B
Based on predictions made at the time of embryo transfer regarding the probability of achieving an ongoing pregnancy during the first IV F cycle. Only the data from couples who underwent embryo transfer during the first cycle were used to develop this model. Data were available from 604 (79.8% of the 757) couples from Nijmegen. To test the model, data could be used from 300 (69.4% of the 432) couples from Eindhoven, At this moment, information was added about preceding events during the cycle as potential prognostic factors, i.e. quality and number of oocytes retrieved, number of oocytes fertilized, quality and number of embryos transferred and whether the transfer had been uncomplicated as indicated by the use of a Wallace catheter, because in difficult cases a sdffer, Frydman catheter was used. In addition, information was known about the experience of the physician who performed the puncture and transfer; this could be used as a potential prognostic factor. Again, the results of cryopreserved embryo transfers were disregarded.
Model C
Based on predictions made at the end of the first IVF cycle regarding the probability of achieving an ongoing pregnancy during the second IV F cycle. To create this model, data were used from couples who did not have an ongoing pregnancy after the first IVF cycle or after a transfer of cryopreserved embryos and who started a second IVF cycle. In Nijmegen and in Eindhoven, 454 and 278 couples started a second IVF cycle respectively. In Eindhoven, information about ongoing pregnancy was lacking for three couples during the second cycle, so the data from 275 couples could be used for the test. In addition to the factors mentioned above, the pregnancy test result after the first IVF cycle was a potential prognostic factor in this model. 0.9 NA = no information available. Number of missing values for duration of infertility in Nijmegen n = 374, bNumber of missing values in Nijmegen: for two ovaries n ~ 1, anti-sperm antibodies $ or 9, and in sperm n ~ 2. cNumber of missing values in Eindhoven: for 1 preceding spontaneous abortions, ectopic pregnancies, deliveries respectively n = 81, 81, 80, for the indications of IVF n -7, for two ovaries n = 9. dDonor spermatozoa were used for three patients. eDonor spermatozoa were used for one patient (the other indication for IVF was tubal factor), fOn a scale from 1 (worst) to 5 (best). 0.5 X the number of tied pairs)/total number of pairs] (Harrell et c il, 1982; 1996) . The c can be interpreted as the probability of a correct prediction for a random pair of a woman with an ongoing pregnancy and a woman without a pregnancy. It is equal to the area under a receiver operating characteristic (ROC) curve (Hanley and McNeil, 1982) . For the development of a prognostic model, the erroneous exclusion of any prognostic factors (because of too little power) would be more deleterious than including too many factors. Therefore these criteria were given a high and low cut-off point respectively; P <0.10 and c >0.005, The variables were selected according to a method akin to a stepwise selection method, Here, the selection criteria is based not only on a P value ( < 0.10), but also on a change in c ( > 0.005). Special attention was given to multicollinearity. If this was present, only the variable with the highest predictive power was included in the multivariate model. If a variable did not meet the criteria in a univariate analysis, it thus could still be included in the prognostic model if the variable met the criteria when it was included in a multivariate model, i.e. after taking into account the prognostic value of other variables. In addition, a variable was omitted from the model if another factor was a stronger predictor and showed Prognosis of ongoing pregnancy after IVF Tabic I I I . Prognostic models for the probability of achieving an ongoing pregnancy (P) during the first in-vitro fertilization (IVF) or second IVF cycle Patients with missing values on one or more of the variables were excluded, i.e. for Nijmegen 0, I and 0, and for Eindhoven 1, 129 and 4 for model A (prediction at start of first IVF cycle regarding probability during first cycle), model B (prediction at embryo transfer regarding probability during first cycle) and model C (prediction at end of first IVF cycle regarding probability during second cycle) respectively.
no additional predictive value. For sperm characteristics combined variables were created and their predictive value was evaluated against that of the separate sperm characteristics.
To test the predictive validity of the models, the data from the other centre were applied. As the data from Nijmegen contained more potential predictors than the data from Eindhoven, the models selected as the best predictive could not always be fully tested. If a specific variable was lacking, the model was modified, if possible, by exchanging it with a similar variable, or otherwise by excluding the variable. To evaluate the reliability of the model, the c was calculated.
If the model had reasonable prognostic value, the predicted probability and the observed result of IVF were compared.
Results

B
The models for predicting the probability of achieving an ongoing pregnancy, developed with the data from Nijmegen and tested with the data from Eindhoven, are presented in Table HI. Model A During the first IVF cycle, 88 (11.6%) out of the 757 women from Nijmegen and 46 (10.6%) out of the 432 women from Eindhoven achieved an ongoing pregnancy. The only factors that had predictive value were a previous gestation and the woman's age. During testing, this model did not show any predictive value when applied to the data from Eindhoven (c = 0.497).
Model B
Embryo transfer was performed in 604 (79.8%) out of the 757 couples from Nijmegen in the first IVF cycle. In Eindhoven, embryo transfer was performed in 300 (69.4%) out of the 432 couples. The ongoing pregnancy rate per transfer was 14.6% in Nijmegen and 15.3% in Eindhoven. The prognostic model included the factors: at least one preceding gestation, the number of fertilized oocytes, the number of transferred embryos and the number of transferred embryos of at least good quality. The probability of achieving an ongoing pregnancy increased if there had been a preceding gestation and the higher the numbers. During the test, this model showed good predictive value (c = 0.672) and good predictive performance, as shown in Table IV . For instance, 93% of the women with a predicted probability of achieving an ongoing pregnancy of <10% did not achieve an ongoing pregnancy after embryo transfer.
Model C
To predict the probability of achieving an ongoing pregnancy during the second IVF cycle, only the data from the couples who received a second treatment could be used. Of the 454 couples who received a second IVF treatment in Nijmegen, 61 (13.4%) achieved an ongoing pregnancy. In Eindhoven this occurred in 29 (10.5%) out of the 275 couples who underwent a second IVF treatment. The best prognostic model is shown in Table III . Of prognostic value were: the woman's age in age-groups, the presence of idiopathic # infertility and embryo transfer during the first IVF cycle. However, this model did not show any predictive value in the test population (c = 0.528).
Discussion
This study showed that models for prediction of ongoing pregnancy due to IVF treatment can be developed with a fairly high prognostic value. However, this does not imply that the same models are predictive for patients treated at another clinic or even at the same clinic. Of the three models, only the one that made a prediction at the time of embryo transfer was fairly reliable in the other population. The other two models that made predictions at the start of treatment or after the first IVF cycle, however, seemed to be of little value when and specificity of a test. The predictive value of a positive test used in Eindhoven. Although model B, which predicts at time is the proportion of patients with a positive test who achieve of embryo transfer, is of little clinical importance, it gives an ongoing pregnancy, and the predictive value of a negative information about the reasons for the inadequacy of the test is the proportion of the patients with a negative test who prediction at the start of the cycle, For the two models at the do not achieve an ongoing pregnancy. Thus, they illustrate start of the cycle, the ovarian response and oocyte aspiration whether the prognosis was right, whereas the sensitivity and are very important, but cannot be included as prognostic factors in the models because this information is not available at the specificity of a test indicate whether the patients who achieved an ongoing pregnancy were classified well by the test. All start of the treatment, whereas in the model that made a these measures can be easily calculated using the data of prediction at time of embryo transfer, the number and quality Table IV . For instance, assume the cut-off point for the test to of the retrieved oocytes are potential prognostic factors.
be a predicted probability of 5%; the test is positive if the Therefore, one explanation for the poor reliability might be differences in the effectiveness of the ovulation simulation predicted probability is 5^5% and negative it <5%. The positive predictive value of this test is 16% (25/155) and the protocols, the long protocol of GnRH agonist in Nijmegen and negative predictive value is 100% (16/16). This demonstrates the short protocol in Eindhoven. No oocyte aspiration was that the test can indicate patients who do not achieve an performed during the first IVF treatment in 7,4% (56 out of ongoing pregnancy after IVF, but cannot predict who achieves the 757) and 21.8% (94 out of the 432) of the women from an ongoing pregnancy. The sensitivity and specificity of this Nijmegen and Eindhoven, respectively. During the second IVF test are 100% (25/25) and 11% (16/146) respectively. treatment, these percentages were 4.6% (21 out of the 454) Obviously, clinicians select their patients before treatment and 15.3% (42 out of the 275) respectively, Not only might with IVF. If the study populations had included more extreme the effectiveness of the ovulation stimulation protocol have groups, those with a very high or a very low probability of influenced the cancellation rate, but also the timing of this success, then the reliability of the prognosis would have been decision differed between the two centres. During the first IVF better. The models we created only apply to populations that cycle, the percentage of cancelled cycles for the reason of too lie within the range of the characteristics presented in Table  many follicles was only 1.8% in Nijmegen, but was as high I. As women of 40 years of age or older were poorly represented as 31.5% in Eindhoven. This decision was made in Nijmegen in Nijmegen (n = 34), the models may not be valid for them, if >25 follicles were present in combination with an oestradiol In addition, information on the duration of infertility was concentration of >20 000 pmol/1, whereas in Eindhoven, cycles only available from 383 patients in Nijmegen. The potential were cancelled when >20 follicles were present. Whether the models developed in Nijmegen can make more accurate prognostic effect of the duration of infertility might not have been detected because of too few observations, predictions if they are applied to an IVF centre that uses a As the data were gathered retrospectively, it was not always long protocol of GnRH agonist and with fewer cancelled possible to obtain full sets of information from the two cycles remains to be seen.
databases. In some cases data were missing, or they were not The present models were adapted to make testing possible, present in the desired form. Moreover, the two hospitals had given the information available in the test population. The their own method of performing IVF and the patient populations changes were negligible. Models A and C were not changed might have differed on other aspects than those studied, at all. In model B the number of follicles >15 mm was
Therefore it was more difficult to create a model that would initially included in the model, but because of lack of this make reliable predictions than if the data had been gathered information in the Eindhoven population, it was exchanged in a standardized way for the purpose of prognostic studies at with the number of fertilized oocytes. Moreover, in model B hospitals which use the same treatment protocols and the same the sperm characteristics <60% normal forms and/or <20X106 definitions for each variable. To make it possible to create spermatozoa per ml added minor predicting value, and were excluded from the model. Note that basal FSH had no additional reliable prognostic models, we recommend setting up uniform national registries which also contain information about the predictive value, nor had the indications for IVF, except for basic fertility workup. idiopathic infertility in model C.
The importance of testing prognostic models is evident. For prognosis, the predictive value of a positive test and of Untested prognostic models can be worthless when used for a negative test are of more practical value than the sensitivity prediction at another (or possibly even the same) IVF clinic.
Before a model can be used by another IVF centre, it should be tested with retrospective data from that centre, to establish whether it is a predictive model in that centre. Even before a model is implemented in the centre where it was developed, it should be tested with an entirely separate set of data from the same centre before one can rely on its predictive properties.
